These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19740399

  • 1. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.
    Hawwa AF, McKiernan PJ, Shields M, Millership JS, Collier PS, McElnay JC.
    Br J Clin Pharmacol; 2009 Sep; 68(3):413-21. PubMed ID: 19740399
    [Abstract] [Full Text] [Related]

  • 2. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
    [Abstract] [Full Text] [Related]

  • 3. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.
    Provenzani A, Notarbartolo M, Labbozzetta M, Poma P, Vizzini G, Salis P, Caccamo C, Bertani T, Palazzo U, Polidori P, Gridelli B, D'Alessandro N.
    Int J Mol Med; 2011 Dec; 28(6):1093-102. PubMed ID: 21922127
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR, Lee W, Jang MS, Chun S, Song GW, Park KT, Lee SG, Han DJ, Kang C, Cho DY, Kim JQ, Min WK.
    Transplantation; 2009 Apr 27; 87(8):1225-31. PubMed ID: 19384171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
    Shi Y, Li Y, Tang J, Zhang J, Zou Y, Cai B, Wang L.
    Gene; 2013 Jan 10; 512(2):226-31. PubMed ID: 23107770
    [Abstract] [Full Text] [Related]

  • 8. The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation.
    de Wildt SN, van Schaik RH, Soldin OP, Soldin SJ, Brojeni PY, van der Heiden IP, Parshuram C, Nulman I, Koren G.
    Eur J Clin Pharmacol; 2011 Dec 10; 67(12):1231-41. PubMed ID: 21698374
    [Abstract] [Full Text] [Related]

  • 9. Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population.
    Rahsaz M, Azarpira N, Nikeghbalian S, Aghdaie MH, Geramizadeh B, Moini M, Banihashemi M, Darai M, Malekpour Z, Malekhosseini SA.
    Exp Clin Transplant; 2012 Feb 10; 10(1):24-9. PubMed ID: 22309416
    [Abstract] [Full Text] [Related]

  • 10. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
    Gómez-Bravo MA, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Alamo JM, Millán O, Brunet M.
    J Clin Pharmacol; 2013 Nov 10; 53(11):1146-54. PubMed ID: 23900887
    [Abstract] [Full Text] [Related]

  • 11. Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation.
    Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA.
    Pharmacogenet Genomics; 2019 Jan 10; 29(1):9-17. PubMed ID: 30489455
    [Abstract] [Full Text] [Related]

  • 12. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Mar 10; 49(3):141-75. PubMed ID: 20170205
    [Abstract] [Full Text] [Related]

  • 13. Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.
    Zhang X, Wang Z, Fan J, Liu G, Peng Z.
    Eur J Clin Pharmacol; 2011 Aug 10; 67(8):803-13. PubMed ID: 21359536
    [Abstract] [Full Text] [Related]

  • 14. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients.
    Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM.
    Pharmacol Rep; 2011 Aug 10; 63(3):815-25. PubMed ID: 21857093
    [Abstract] [Full Text] [Related]

  • 15. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients.
    Genvigir FD, Salgado PC, Felipe CR, Luo EY, Alves C, Cerda A, Tedesco-Silva H, Medina-Pestana JO, Oliveira N, Rodrigues AC, Doi SQ, Hirata MH, Hirata RD.
    Pharmacogenet Genomics; 2016 Oct 10; 26(10):462-72. PubMed ID: 27434656
    [Abstract] [Full Text] [Related]

  • 16. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III).
    Yoon SH, Cho JH, Kwon O, Choi JY, Park SH, Kim YL, Yoon YR, Won DI, Kim CD.
    Transplantation; 2013 Mar 27; 95(6):828-34. PubMed ID: 23364483
    [Abstract] [Full Text] [Related]

  • 17. Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients.
    Miao LY, Huang CR, Hou JQ, Qian MY.
    Biopharm Drug Dispos; 2008 Jan 27; 29(1):1-5. PubMed ID: 17941052
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.
    Sallustio BC, Noll BD, Hu R, Barratt DT, Tuke J, Coller JK, Russ GR, Somogyi AA.
    Br J Clin Pharmacol; 2021 Oct 27; 87(10):3901-3909. PubMed ID: 33646566
    [Abstract] [Full Text] [Related]

  • 19. A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation.
    Sy SK, Heuberger J, Shilbayeh S, Conrado DJ, Derendorf H.
    AAPS J; 2013 Oct 27; 15(4):1189-99. PubMed ID: 23990505
    [Abstract] [Full Text] [Related]

  • 20. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
    Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA.
    Basic Clin Pharmacol Toxicol; 2018 Sep 27; 123(3):320-326. PubMed ID: 29603629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.